Novozymes A/S
NVZMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $180,353 | $100,140 | $97,476 | $149,525 |
| - Cash | $280 | $1,116 | $1,041 | $963 |
| + Debt | $1,797 | $7,733 | $919 | $482 |
| Enterprise Value | $181,870 | $106,757 | $97,354 | $149,044 |
| Revenue | $28,590 | $17,906 | $17,553 | $14,951 |
| % Growth | 59.7% | 2% | 17.4% | – |
| Gross Profit | $14,867 | $9,726 | $9,590 | $8,638 |
| % Margin | 52% | 54.3% | 54.6% | 57.8% |
| EBITDA | $8,071 | $5,643 | $5,721 | $5,061 |
| % Margin | 28.2% | 31.5% | 32.6% | 33.9% |
| Net Income | $2,281 | $3,026 | $3,676 | $3,146 |
| % Margin | 8% | 16.9% | 20.9% | 21% |
| EPS Diluted | 0.67 | 10.88 | 13.19 | 11.23 |
| % Growth | -93.8% | -17.5% | 17.5% | – |
| Operating Cash Flow | $1,020 | $4,152 | $4,006 | $4,062 |
| Capital Expenditures | -$360 | -$2,056 | -$2,890 | -$1,240 |
| Free Cash Flow | $660 | $2,096 | $1,116 | $2,822 |